Anti-CD25 antibodies (daclizumab) as renal sparing immunosuppression after liver transplantation.
A
A
Alakkari
D
D
Maguire
J
J
Geoghegan
J E
JE
Hegarty
O
O
Traynor
A
A
Watson
P A
PA
McCormick
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000077561:Daclizumab; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology*; D051437:Renal Insufficiency / Q000188:drug therapy*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D000077561:Daclizumab